
|Articles|December 15, 2002
Imiquimod vs. Interferon
Paris - Imiquimod 5 percent cream (Aldara), like intralesional interferon, may prevent keloid recurrence. And although imiquimod use may necessitate longer treatment - up to eight weeks compared to two injections of interferon - the drug is without adverse systemic reactions, Ivonne Arellano, M.D., said at the World Congress of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5


















